Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
ObjectiveThis study aimed to investigate the potential predictive factors for platinum resistance and poor prognosis in epithelial ovarian, fallopian tube, and primary peritoneal cancer treated with platinum-based chemotherapy.MethodsMedical records of 306 patients with the above mentioned cancers t...
Saved in:
Main Authors: | Dhammapoj Jeerakornpassawat (Author), Prapaporn Suprasert (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Obstetrics and Gynecology,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
by: Shoji Nagao, et al.
Published: (2020) -
Micturition symptoms in gynecologic cancer patients receiving paclitaxel and platinum-based chemotherapy regimen: a prospective study
by: Jongpeeti Wudtisan, et al.
Published: (2023) -
A retrospective study of Pipelle endometrial biopsy for ovarian, fallopian tube, and peritoneal cancers
by: Ryo Tamura, et al.
Published: (2023) -
High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer
by: Sooji Ham, et al.
Published: (2023) -
Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)
by: Elizabeth K. Lee, et al.
Published: (2020)